NTrans Technologies collaborates with several Universities and companies for further development and market introduction of the iTOP technology.


EFRO logo


NTrans technologies has been awarded with a grant on the basis of the “Operationeel Programma Kansen voor West II”. The project is focused on further development of “iTOP technology as basis for the development of a new productportfolio” for both in vitro as well as in vivo applications.




New therapies for the treatment of genetic diseases and cancer
Contact us